Agree with you, I saw no reason why the Sophs would put money into a share for as little as .002cents per share although it may represent 10%.
Looking like, we are almost ready for the rerate any time now. I bought more at 2.4 cents, wanted to buy more at or below 2.2c. The reason is we have a steadily growing company on one hand and a dying opposition at the other hand, in an atmosphere of a growing cannabis market. Like others who think similar, I am surprised why many have residual concerns? If you can name a few with better potential I am keen to know while I hope ECS becomes a game changer for all holders. GLTAH
Ann: Half Yearly Report and Accounts, page-43
-
- There are more pages in this discussion • 21 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ECS (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.7¢ |
Change
-0.001(5.56%) |
Mkt cap ! $23.19M | |||
| Open | High | Low | Value | Volume |
| 1.8¢ | 1.8¢ | 1.7¢ | $5.085K | 295.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 17513 | 1.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.8¢ | 2090919 | 4 |
View Market Depth
| Last trade - 11.58am 21/06/2024 (20 minute delay) ? |
| ECS (ASX) Chart |